Breaking

WPIC: Platinum Market Set for 2026 Stability After Years of Deep Deficits
Stonegate Capital Partners Updates Coverage on Heliostar Metals Ltd2Q26
Anteros Metals Inc. Announces Closing of Final Tranche of Private Placement
Crypto Market Update: Bitcoin Logs Weakest Month Since 2022
What AI bubble? Nvidia’s strong earnings signal there’s more room to grow
Crypto Market Update: Bitcoin Price Slide Continues, Kraken Files for IPO
Skyharbour Engages Emerging Markets Consulting LLC for Marketing Contract
Heliostar Presents Third Quarter 2025 Financial Results

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

By May 12, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

WPIC: Platinum Market Set for 2026 Stability After Years of Deep Deficits

November 21, 2025

Stonegate Capital Partners Updates Coverage on Heliostar Metals Ltd2Q26

November 21, 2025

Crypto Market Update: Bitcoin Logs Weakest Month Since 2022

November 21, 2025

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (1,026)
- Editor's Pick (633)
- Investing (5,104)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.